(Q37521939)

20 August 2017

1 reference

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate (English)

1 reference

20 August 2017

1 reference

1

Joachim Boldt

0 references

publication date

17 June 2009

1 reference

20 August 2017

published in

Intensive Care Medicine

1 reference

20 August 2017

volume

35

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

1331-1336

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-009-1520-6

20 August 2017

exact match

0 references

cites work

RETRACTED: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-009-1520-6

Hydroxyethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis

21 January 2018

1 reference

12 December 2020

Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study

1 reference

12 December 2020

The risk associated with hyperoncotic colloids in patients with shock

1 reference

12 December 2020

Volume replacement in critically ill patients with acute renal failure

1 reference

12 December 2020

Fluid resuscitation and the septic kidney

1 reference

12 December 2020

Acute renal failure precipitated by elevated colloid osmotic pressure

1 reference

12 December 2020

Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation

1 reference

12 December 2020

Colloids versus crystalloids for fluid resuscitation in critically ill patients

1 reference

12 December 2020

Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?

1 reference

12 December 2020

Acute renal failure associated with elevated plasma oncotic pressure

1 reference

12 December 2020

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

1 reference

12 December 2020

Renal tubular cellular and molecular events in acute renal failure

1 reference

12 December 2020

Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial

1 reference

12 December 2020

Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers

1 reference

12 December 2020

The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment

1 reference

12 December 2020

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

1 reference

12 December 2020

HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly

1 reference

12 December 2020

Renal impact of fluid management with colloids: a comparative review

1 reference

12 December 2020

RETRACTED: Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function?

1 reference

12 December 2020

Colloid solutions for fluid resuscitation

1 reference

12 December 2020

Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury

1 reference

12 December 2020

RETRACTED: Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients

1 reference

12 December 2020

Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery

1 reference

12 December 2020

Pharmacokinetics of hydroxyethyl starch

1 reference

12 December 2020

Preferred plasma volume expanders for critically ill patients: results of an international survey

1 reference

12 December 2020

Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis

1 reference

12 December 2020

Effects of hydroxyethyl starch administration on renal function in critically ill patients † ‡

1 reference

12 December 2020

RETRACTED: Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin

1 reference

12 December 2020

Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation

1 reference

12 December 2020

Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?

1 reference

12 December 2020

Volume therapy in the critically ill: is there a difference?

1 reference

12 December 2020

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.

1 reference

12 December 2020

RETRACTED: Volume therapy in the critically ill: is there a difference?

1 reference

12 December 2020

10.1007/S00134-009-1520-6

Identifiers

DOI

1 reference

20 August 2017

1 reference